Product claims may differ from country to country based on regulations and product approvals. Please contact your country representative for further details.

»  Search

 


Advanced search



History

1994
  • Formation of B·R·A·H·M·S Diagnostica GmbH.
  • First MBO of the German pharmaceuticals industry from the former Diagnostic Procedures business segment of Henning Berlin/Marion Merrell Dow.
1995
  • Extension of the business activities to crucial research in the fields of thyroid diseases, auto-immune diseases, and life-threatening infections.
1996
  • Product placement of PCT, the first test procedure for an early detection of sepsis.
1997
  • Foundation of B·R·A·H·M·S France S.A.R.L. in Paris and other subsidiaries.
  • ISO 9001 – certified quality management.
1999
  • Product placement of a quick sepsis test in the point-of-care format.
  • Product placement of TRAKhuman, by now the established procedure for the diagnosis of Graves disease.
  • Foundation of the Biotech Centre Hennigsdorf.
2000
  • Takeover of the KRYPTOR laboratory system.
  • Foundation of Cezanne SAS in Bagnols sur Cèze, France.
2001
  • Transformation into a stock corporation.
2002
  • Cezanne S.A.S. facilities destroyed as a result of a catastrophic flood in southern France
  • Company relocates to new premises in Nîmes
2003
  • Focus on diagnostics business
2004
  • Tenth anniversary celebration with ceremony at the Axica Forum on Berlin’s Pariser Platz
  • Additional benefit of PCT test in antibiotic therapies announced in The Lancet
2005
  • Manual PCT test approved by FDA for use in the United States
  • New shareholder structure
2006
  • New clinical developments for new cardiac biomarkers
  • Sales record of 50 million Euro reached in December
2007
  • Foundation of BRAHMS UK Ltd in November
  • New Sales record of 60 million Euro reached in December
2008
  • Foundation of BRAHMS Italia Srl. in February
  • FDA-Clearance of PCT Kryptor-test in USA
2009
  • Foundation of BRAHMS Iberia S.L. in May
  • In September: B·R·A·H·M·S and Thermo Fischer Scientific join forces to create a leader in specialty diagnostics.
  • Competition Authorities approve Acquisition of B·R·A·H·M·S by Thermo Fisher Scientific
2010
  • Transformation into a GmbH (private limited company) on May 27, 2010